Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

79372

registered interest
date	22/07/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Idiopathic Pulmonary Fibrosis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps his Department is taking to raise awareness of idiopathic pulmonary fibrosis among healthcare professionals.
tabling member constituency	Brigg and Goole
tabling member printed	Andrew Percy
uin	207026
answer	answer is ministerial correction date of answer 01/09/2014 answer text <p>Information for both health professionals and patients about idiopathic pulmonary fibrosis (IPF) is available on the National institute for Health and Clinical Excellence (NICE) website at the following link:</p><p> </p><p>www.nice.org.uk/Guidance/Conditions-and-diseases/Respiratory-conditions/Pulmonary-fibrosis</p><p> </p><p>A guideline for IPF and a NICE Technology Appraisal for Pirfenidone as a treatment for IPF are available and an IPF Quality Standard is currently in development.</p><p>The British Lung Foundation also offers advice which can be found at:</p><p>www.blf.org.uk/Search?query=idiopathic+pulmonary+fibrosis</p><p> </p><p>Patient and public voice members are represented on the Specialised Respiratory Clinical Reference Group. Details can be found at:</p><p>www.england.nhs.uk/ourwork/commissioning/spec-services/npc-crg/group-a/a14/</p><p>The NHS standard contract for interstitial lung disease makes reference to the additional roles that specialist centres providing care have in relation to patient education and patient support groups.</p><p>www.england.nhs.uk/wp-content/uploads/2013/06/a14-respiratory-inters-lung.pdf</p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 207029 question first answered 01/09/2014 13:32:32 answering member 3918 label Biography information for Jane Ellison
tabling member	3939 label Biography information for Andrew Percy

79373

registered interest
date	22/07/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Idiopathic Pulmonary Fibrosis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many patients with idiopathic pulmonary fibrosis in England and Wales are currently considered eligible for lung transplantation.
tabling member constituency	Brigg and Goole
tabling member printed	Andrew Percy
uin	207027
answer	answer is ministerial correction date of answer 01/09/2014 answer text <p>We are advised by NHS Blood and Transplant that, as at 24 July 2014, there were 72 patients with idiopathic pulmonary fibrosis resident in England and Wales considered eligible for lung transplantation and currently listed for a lung transplant (where the primary disease is recorded as fibrosing lung disease).</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 01/09/2014 13:54:34 answering member 3918 label Biography information for Jane Ellison
tabling member	3939 label Biography information for Andrew Percy

79375

registered interest
date	22/07/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Idiopathic Pulmonary Fibrosis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how much funding his Department has designated for research into idiopathic pulmonary fibrosis in 2014-15.
tabling member constituency	Brigg and Goole
tabling member printed	Andrew Percy
uin	207028
answer	answer is ministerial correction date of answer 01/09/2014 answer text <p>Total spend in the current and future financial years by the Department’s National Institute for Health Research (NIHR) on research on idiopathic pulmonary fibrosis (IPF) depends on the volume and quality of scientific activity. The usual practice of the NIHR is not to designate funds for expenditure on particular topics: research proposals in all areas compete for the funding available. The NIHR welcomes funding applications for research into any aspect of human health, including IPF. These applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and the National Health Service, value for money and scientific quality.</p><p> </p><p>In 2013-14, the NIHR spent £0.6 million on research on IPF through research programmes, research centres and units, and research fellowships. Total spend by the NIHR on research on this disease is higher than this because expenditure by the NIHR Clinical Research Network (CRN) on IPF cannot be disaggregated from total CRN expenditure.</p><p> </p> answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter question first answered 01/09/2014 13:24:50 answering member 3932 label Biography information for Dr Dan Poulter
tabling member	3939 label Biography information for Andrew Percy

79376

registered interest
date	22/07/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Idiopathic Pulmonary Fibrosis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what processes are in place to ensure that idiopathic pulmonary fibrosis patients in the NHS and their families have access to high quality information about that condition.
tabling member constituency	Brigg and Goole
tabling member printed	Andrew Percy
uin	207029
answer	answer is ministerial correction date of answer 01/09/2014 answer text <p>Information for both health professionals and patients about idiopathic pulmonary fibrosis (IPF) is available on the National institute for Health and Clinical Excellence (NICE) website at the following link:</p><p> </p><p>www.nice.org.uk/Guidance/Conditions-and-diseases/Respiratory-conditions/Pulmonary-fibrosis</p><p> </p><p>A guideline for IPF and a NICE Technology Appraisal for Pirfenidone as a treatment for IPF are available and an IPF Quality Standard is currently in development.</p><p>The British Lung Foundation also offers advice which can be found at:</p><p>www.blf.org.uk/Search?query=idiopathic+pulmonary+fibrosis</p><p> </p><p>Patient and public voice members are represented on the Specialised Respiratory Clinical Reference Group. Details can be found at:</p><p>www.england.nhs.uk/ourwork/commissioning/spec-services/npc-crg/group-a/a14/</p><p>The NHS standard contract for interstitial lung disease makes reference to the additional roles that specialist centres providing care have in relation to patient education and patient support groups.</p><p>www.england.nhs.uk/wp-content/uploads/2013/06/a14-respiratory-inters-lung.pdf</p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 207026 question first answered 01/09/2014 13:32:32 answering member 3918 label Biography information for Jane Ellison
tabling member	3939 label Biography information for Andrew Percy

62319

registered interest
date	17/06/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Food
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, on what criteria his Department differentiates a food for special medical purposes and a food supplement.
tabling member constituency	Brigg and Goole
tabling member printed	Andrew Percy
uin	201119
answer	answer is ministerial correction date of answer 23/06/2014 answer text <p>The Department's role and the definition of these products are set out in legislation. Information on this legislation is available at:</p><p> </p><p>www.gov.uk/government/publications/food-supplements-guidance-and-faqs</p><p> </p><p>www.gov.uk/government/publications/infant-formula-and-foods-for-particular-nutritional-uses-parnuts-notification-requirements</p><p> </p><p>Local authorities are responsible for enforcement of the legislation and provide advice to businesses on compliance with legislation.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 201120 question first answered 23/06/2014 15:12:55 answering member 3918 label Biography information for Jane Ellison
tabling member	3939 label Biography information for Andrew Percy

62322

registered interest
date	17/06/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Food
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, if he will outline the process, criteria and guidelines that his Department follows to evaluate foods for special medical purposes for the UK market; what criteria his Department uses for such evaluations; and what guidance his Department issues on foods for special medical purposes.
tabling member constituency	Brigg and Goole
tabling member printed	Andrew Percy
uin	201120
answer	answer is ministerial correction date of answer 23/06/2014 answer text <p>The Department's role and the definition of these products are set out in legislation. Information on this legislation is available at:</p><p> </p><p>www.gov.uk/government/publications/food-supplements-guidance-and-faqs</p><p> </p><p>www.gov.uk/government/publications/infant-formula-and-foods-for-particular-nutritional-uses-parnuts-notification-requirements</p><p> </p><p>Local authorities are responsible for enforcement of the legislation and provide advice to businesses on compliance with legislation.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 201119 question first answered 23/06/2014 15:12:55 answering member 3918 label Biography information for Jane Ellison
tabling member	3939 label Biography information for Andrew Percy